-
A randomized, double-blind, controlled study to evaluate clinical efficacy and safety of novel filmogen osmotic treatment for pharyngitis
Monika Rousse, Hendrik Schutte, Martine Guy, Gael Clairefond, Ravi Shrivastava
Research Article: Clinical Investigation
-
A randomized, double-blind, controlled study to evaluate clinical efficacy and safety of novel filmogen osmotic treatment for pharyngitis
Monika Rousse, Hendrik Schutte, Martine Guy, Gael Clairefond, Ravi Shrivastava
Research Article: Clinical Investigation
-
A randomized, double-blind, controlled study to evaluate clinical efficacy and safety of novel filmogen osmotic treatment for pharyngitis
Monika Rousse, Hendrik Schutte, Martine Guy, Gael Clairefond, Ravi Shrivastava
Research Article: Clinical Investigation
-
A randomized, double-blind, controlled study to evaluate clinical efficacy and safety of novel filmogen osmotic treatment for pharyngitis
Monika Rousse, Hendrik Schutte, Martine Guy, Gael Clairefond, Ravi Shrivastava
Research Article: Clinical Investigation
-
A randomized, double-blind, controlled study to evaluate clinical efficacy and safety of novel filmogen osmotic treatment for pharyngitis
Monika Rousse, Hendrik Schutte, Martine Guy, Gael Clairefond, Ravi Shrivastava
Research Article: Clinical Investigation
-
A randomized, double-blind, controlled study to evaluate clinical efficacy and safety of novel filmogen osmotic treatment for pharyngitis
Monika Rousse, Hendrik Schutte, Martine Guy, Gael Clairefond, Ravi Shrivastava
Research Article: Clinical Investigation
-
A randomized, double-blind, controlled study to evaluate clinical efficacy and safety of novel filmogen osmotic treatment for pharyngitis
Monika Rousse, Hendrik Schutte, Martine Guy, Gael Clairefond, Ravi Shrivastava
Research Article: Clinical Investigation
-
A randomized, double-blind, controlled study to evaluate clinical efficacy and safety of novel filmogen osmotic treatment for pharyngitis
Monika Rousse, Hendrik Schutte, Martine Guy, Gael Clairefond, Ravi Shrivastava
Research Article: Clinical Investigation
-
MESOS: considerations in designing a mechanistic study for a biologic used to treat asthma
Christopher Brightling, Millie Wang, Martin Braddock, Lars Nordenmark, Mattis Gottlow & Gene Colice
Clinical Trail Perspective: Clinical Investigation
-
MESOS: considerations in designing a mechanistic study for a biologic used to treat asthma
Christopher Brightling, Millie Wang, Martin Braddock, Lars Nordenmark, Mattis Gottlow & Gene Colice
Clinical Trail Perspective: Clinical Investigation
-
MESOS: considerations in designing a mechanistic study for a biologic used to treat asthma
Christopher Brightling, Millie Wang, Martin Braddock, Lars Nordenmark, Mattis Gottlow & Gene Colice
Clinical Trail Perspective: Clinical Investigation
-
MESOS: considerations in designing a mechanistic study for a biologic used to treat asthma
Christopher Brightling, Millie Wang, Martin Braddock, Lars Nordenmark, Mattis Gottlow & Gene Colice
Clinical Trail Perspective: Clinical Investigation
-
MESOS: considerations in designing a mechanistic study for a biologic used to treat asthma
Christopher Brightling, Millie Wang, Martin Braddock, Lars Nordenmark, Mattis Gottlow & Gene Colice
Clinical Trail Perspective: Clinical Investigation
-
MESOS: considerations in designing a mechanistic study for a biologic used to treat asthma
Christopher Brightling, Millie Wang, Martin Braddock, Lars Nordenmark, Mattis Gottlow & Gene Colice
Clinical Trail Perspective: Clinical Investigation
-
MESOS: considerations in designing a mechanistic study for a biologic used to treat asthma
Christopher Brightling, Millie Wang, Martin Braddock, Lars Nordenmark, Mattis Gottlow & Gene Colice
Clinical Trail Perspective: Clinical Investigation
-
MESOS: considerations in designing a mechanistic study for a biologic used to treat asthma
Christopher Brightling, Millie Wang, Martin Braddock, Lars Nordenmark, Mattis Gottlow & Gene Colice
Clinical Trail Perspective: Clinical Investigation
-
Non-inferiority designs and novel antimicrobials
Giorgio Tarchini
Editorial: Clinical Investigation
-
Non-inferiority designs and novel antimicrobials
Giorgio Tarchini
Editorial: Clinical Investigation
-
Non-inferiority designs and novel antimicrobials
Giorgio Tarchini
Editorial: Clinical Investigation
-
Non-inferiority designs and novel antimicrobials
Giorgio Tarchini
Editorial: Clinical Investigation
-
Non-inferiority designs and novel antimicrobials
Giorgio Tarchini
Editorial: Clinical Investigation
-
Non-inferiority designs and novel antimicrobials
Giorgio Tarchini
Editorial: Clinical Investigation
-
Non-inferiority designs and novel antimicrobials
Giorgio Tarchini
Editorial: Clinical Investigation
-
Non-inferiority designs and novel antimicrobials
Giorgio Tarchini
Editorial: Clinical Investigation
-
The presumption of benefit in clinical research with children and adolescents
Janet L Brody
Editorial: Clinical Investigation
-
The presumption of benefit in clinical research with children and adolescents
Janet L Brody
Editorial: Clinical Investigation
-
The presumption of benefit in clinical research with children and adolescents
Janet L Brody
Editorial: Clinical Investigation
-
The presumption of benefit in clinical research with children and adolescents
Janet L Brody
Editorial: Clinical Investigation
-
The presumption of benefit in clinical research with children and adolescents
Janet L Brody
Editorial: Clinical Investigation
-
The presumption of benefit in clinical research with children and adolescents
Janet L Brody
Editorial: Clinical Investigation
-
The presumption of benefit in clinical research with children and adolescents
Janet L Brody
Editorial: Clinical Investigation
-
The presumption of benefit in clinical research with children and adolescents
Janet L Brody
Editorial: Clinical Investigation
-
New advances in the treatment of Friedreich ataxia: promises and pitfalls
Wolfgang Nachbauer, Sylvia Boesch
Therapeutic Prospective: Clinical Investigation
-
New advances in the treatment of Friedreich ataxia: promises and pitfalls
Wolfgang Nachbauer, Sylvia Boesch
Therapeutic Prospective: Clinical Investigation
-
New advances in the treatment of Friedreich ataxia: promises and pitfalls
Wolfgang Nachbauer, Sylvia Boesch
Therapeutic Prospective: Clinical Investigation
-
New advances in the treatment of Friedreich ataxia: promises and pitfalls
Wolfgang Nachbauer, Sylvia Boesch
Therapeutic Prospective: Clinical Investigation
-
New advances in the treatment of Friedreich ataxia: promises and pitfalls
Wolfgang Nachbauer, Sylvia Boesch
Therapeutic Prospective: Clinical Investigation
-
New advances in the treatment of Friedreich ataxia: promises and pitfalls
Wolfgang Nachbauer, Sylvia Boesch
Therapeutic Prospective: Clinical Investigation
-
New advances in the treatment of Friedreich ataxia: promises and pitfalls
Wolfgang Nachbauer, Sylvia Boesch
Therapeutic Prospective: Clinical Investigation
-
New advances in the treatment of Friedreich ataxia: promises and pitfalls
Wolfgang Nachbauer, Sylvia Boesch
Therapeutic Prospective: Clinical Investigation